No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas [15]

Journal of Clinical Oncology

Volumn 23, Issue 13, 2005, Pages 3167-3168

  De Preter, Katleen ^a   Speleman, Frank ^a   Combaret, Valérie ^b   Lunec, John ^c   Board, Julian ^c   Pearson, Andy ^c   De Paepe, Anne ^a   Van Roy, Nadine ^a   Laureys, Geneviève ^a   Vandesompele, Jo ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CENTRE LÉON BÉRARD   (France)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CORRELATION ANALYSIS; DDX1 GENE; GENE; GENE AMPLIFICATION; HUMAN; LETTER; NEUROBLASTOMA; ONCOGENE MYC; PRIORITY JOURNAL; PROGNOSIS; FOLLOW UP; GENETICS; NOTE; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SURVIVAL;

DDX1 PROTEIN, HUMAN; DEAD BOX PROTEIN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; RNA HELICASE;

DEAD-BOX RNA HELICASES; FOLLOW-UP STUDIES; GENE AMPLIFICATION; HUMANS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA HELICASES; SURVIVAL ANALYSIS;

EID: 21144441498     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.346     Document Type: Letter

References (3)

1. Weber A, Imisch P, Bergmann E, et al: Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma. J Clin Oncol 22:2681-2690, 2004
2. De Preter K, Speleman F, Combaret V, et al: Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 15:159-166, 2002
3. Scott D, Elsden J, Pearson A, et al: Genes co-amplified with MYCN in neuroblastoma: Silent passengers or co-determinants of phenotype? Cancer Lett 197:81-86, 2003